POSTED: July 15th, 2017
POSTED IN: Legislative Updates,
The House approved the “FDA Reauthorization Act of 2017” (H.R. 2430) by voice vote. The bill would reauthorize the Prescription Drug User Fee Act, the Medical Device User Fee Amendments, the Generic Drug User Fee Amendments and the Biosimilar User Fee Act, as well as modify the FDA’s drug review process. The Senate has a similar version of the bill, S. 934.